Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,646 | 1,919 | 9 | 112 | 25 |
| Marketable Securities | 9 | 9 | 9 | 9 | 9 |
| Inventories | 31 | 155 | 156 | 156 | 100 |
| Other current assets | 90 | 187 | 200 | 200 | 0 |
| TOTAL | $2,087 | $2,796 | $404 | $494 | $157 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 0 | 29 |
| Other Non-Current Assets | 117 | 0 | 0 | 0 | 200 |
| TOTAL | $117 | $N/A | $N/A | $N/A | $229 |
| Total Assets | $2,204 | $2,796 | $404 | $494 | $387 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 144 | 62 | N/A |
| Accounts payable and accrued liabilities | 115 | 73 | 106 | 55 | 63 |
| TOTAL | $122 | $80 | $266 | $117 | $88 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12 | 12 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 400 | 400 | 400 | 400 |
| TOTAL | $12 | $412 | $400 | $400 | $400 |
| Total Liabilities | $134 | $492 | $666 | $517 | $488 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,142 | 85,142 | 83,142 | 23,604 | 23,493 |
| Common Shares | 9 | 8 | 2 | 2 | 2 |
| Retained earnings | -4,973 | -4,339 | -2,895 | -2,656 | -2,274 |
| TOTAL | $2,071 | $2,304 | $-262 | $-23 | $-101 |
| Total Liabilities And Equity | $2,204 | $2,796 | $404 | $494 | $387 |